Cargando…

Untapping host-targeting cross-protective efficacy of anticoagulants against SARS-CoV-2

Responding quickly to emerging respiratory viruses, such as SARS-CoV-2 the causative agent of coronavirus disease 2019 (COVID-19) pandemic, is essential to stop uncontrolled spread of these pathogens and mitigate their socio-economic impact globally. This can be achieved through drug repurposing, wh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niemeyer, Brian F., Benam, Kambez H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552695/ https://www.ncbi.nlm.nih.gov/pubmed/34718070 http://dx.doi.org/10.1016/j.pharmthera.2021.108027

Ejemplares similares

Broad antiviral and anti‐inflammatory efficacy of nafamostat against SARS‐CoV‐2 and seasonal coronaviruses in primary human bronchiolar epithelia
por: Niemeyer, Brian F., et al.
Publicado: (2021)

Where We Stand: Lung Organotypic Living Systems That Emulate Human-Relevant Host–Environment/Pathogen Interactions
por: Jimenez-Valdes, Rocio J., et al.
Publicado: (2020)

BPIFA1 is a secreted biomarker of differentiating human airway epithelium
por: Clifton, Clarissa, et al.
Publicado: (2022)

Cross-viral protection against SARS-CoV-2?
por: Reed, Sophie G.
Publicado: (2020)

Host-directed therapy, an untapped opportunity for antimalarial intervention
por: Wei, Ling, et al.
Publicado: (2021)

Editorial: Accelerated Translation Using Microphysiological Organoid and Microfluidic Chip Models
por: Benam, Kambez H., et al.
Publicado: (2022)

Protocol for the operation of a breathing and vaping biomimetic robot to delineate real-time inhaled particle profile of electronic cigarettes
por: Bogdanoff, Rachel F., et al.
Publicado: (2022)

Untapped Agility
por: Fewell, Jesse
Publicado: (2020)

Untapped policy avenues to protect coral reef ecosystems
por: Carlson, Rachel R., et al.
Publicado: (2022)

Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
por: Yu, Jingyou, et al.
Publicado: (2022)

Electronic cigarette menthol flavoring is associated with increased inhaled micro and sub-micron particles and worse lung function in combustion cigarette smokers
por: Chandra, Divay, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Primary Immune Response Provides Protective Efficacy against SARS-CoV-2 Reinfection
por: Shrestha, Rupendra, et al.
Publicado: (2021)

Association of anticoagulation use with SARS-CoV2 detection()
por: Kavecansky, Juraj, et al.
Publicado: (2021)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

HCQ use not protective against SARS-CoV-2
por: Onuora, Sarah
Publicado: (2020)

Children are protected against SARS-CoV-2 infection
por: Dimeglio, Chloé, et al.
Publicado: (2020)

IL-13 Protects against SARS-CoV-2?
por: Peebles, R. Stokes
Publicado: (2022)

Omicron Infection Evokes Cross-Protection against SARS-CoV-2 Variants in Vaccinees
por: Anichini, Gabriele, et al.
Publicado: (2022)

Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2
por: Osaka, Toshifumi, et al.
Publicado: (2023)

Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections
por: Yang, Ren, et al.
Publicado: (2020)

Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants
por: Noor, Rashed
Publicado: (2022)

Antiviral Efficacy of Pralatrexate against SARS-CoV-2
por: Bae, Joon-Yong, et al.
Publicado: (2021)

Untapping the Potential of Astragaloside IV in the Battle Against Respiratory Diseases
por: Tan, Junlan, et al.
Publicado: (2023)

Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques
por: Yu, Jingyou, et al.
Publicado: (2021)

Alternative Spliced CD1D Transcripts in Human Bronchial Epithelial Cells
por: Benam, Kambez Hajipouran, et al.
Publicado: (2011)

Commentary: The untapped potential of protective eyewear for primary prevention of ocular trauma
por: Sinha, Sony, et al.
Publicado: (2023)

The student workforce: untapped possibilities
por: Anderson, Elizabeth S, et al.
Publicado: (2020)

Bioimpedance in CKD: an untapped resource?
por: Mayne, Kaitlin J, et al.
Publicado: (2022)

Protections against the Risk of Airborne SARS-CoV-2 Infection
por: McDonald, Clement J.
Publicado: (2020)

Dissecting antibody-mediated protection against SARS-CoV-2
por: Zohar, Tomer, et al.
Publicado: (2020)

The role of masks and respirator protection against SARS-CoV-2
por: Wang, Qiang, et al.
Publicado: (2020)

Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques
por: McMahan, Katherine, et al.
Publicado: (2020)

Correlates of Vaccine-Induced Protection against SARS-CoV-2
por: Koch, Till, et al.
Publicado: (2021)

Genetic Variants and Protective Immunity against SARS-CoV-2
por: Rabaan, Ali A., et al.
Publicado: (2022)

Infectivity of SARS-CoV-2 and protection against reinfection in rats
por: Yu, Dandan, et al.
Publicado: (2022)

Protective Efficacy of Inactivated Vaccine against SARS-CoV-2 Infection in Mice and Non-Human Primates
por: Yao, Yan-Feng, et al.
Publicado: (2021)

Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants
por: Li, Tingting, et al.
Publicado: (2021)

Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2
por: Tostanoski, Lisa H., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_si2kipvutrk9rgbemo9clc6lo0